Class Action Alleges Plot To Price-Fix Plasma Therapies

Law360, New York (November 11, 2009, 4:55 PM EST) -- Pharmaceutical companies CSL Ltd. Co. and Baxter International Inc. are facing class action allegations that they conspired to fix the prices of plasma-derivative protein therapies.

In a 66-page amended complaint filed Tuesday with the U.S. District Court for the Eastern District of Pennsylvania, plaintiff Pemiscot Memorial Hospital alleges that because of the defendants' actions, members of a proposed class paid improperly high prices for the plasma-derivative protein therapies.

Plasma-derivative protein therapies, according to the complaint, are used to treat critically ill patients suffering from various immune...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.